The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 5.00 (0.29%)
Spread: 0.50 (0.029%)
Open: 1,733.00
High: 1,739.50
Low: 1,724.50
Prev. Close: 1,728.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LIVE MARKETS-Time to give UK PLC a break

Mon, 20th Jul 2020 12:15

* European stocks slightly up

* EU talks in focus

* Italy's UBI surges after Intesa raises bid by 18%
Welcome to the home for real-time coverage of European equity markets brought to you by Reuters
stocks reporters. You can share your thoughts Joice Alves (joice.alves@thomsonreuters.com) and
Julien Ponthus (julien.ponthus@thomsonreuters.com) in London and Stefano Rebaudo
(stefano.rebaudo@thomsonreuters.com) in Milan.

TIME TO GIVE UK PLC A BREAK (1115 GMT)

There hasn't been much love for shares in UK PLC since, well... quite some time now.
Remember that Brexit referendum way back in 2016?

As JPM analysts recall in their latest global strategy note, the "UK has now lagged global
peers in each of the last 5 years, as well as ytd, and this underperformance is not just due to
the strong U.S. run".

Nope, as they stress, the "UK has lost out vs the rest of Europe by a cumulative 25% over
that timeframe".

As we speak, the FTSE 100 is the top underperformer in Europe today as investors wait for EU
leaders to deliver a deal on their stimulus plan.

With hard Brexit fears still running high and a somewhat underwhelming response to the
COVID-19 pandemic, this wouldn't look like the perfect moment for a change of heart but JPM
analysts believe it's time to give UK PLC a break.

"We now believe that the relative risk-reward for UK is finally starting to improve, and are
closing our UW", they announced this morning, noting how cheap UK shares are trading and how the
dividend fallout is less of an issue now that the dust is settling on pay-outs.

JPM analysts say however that they are not convinced the British stock market has yet become
a value trade but they identified interesting sectors such as homebuilders and utilities.

If the pound remains weak, mining, pharma, staples and tech could also prove good
investments.

Here are two charts from the report showing the underperformance of UK PLC and how cheap it
is trading:

(Julien Ponthus)

*****

IS BIG CASH FROM CENTRAL BANKS PROLONGING THE CRISIS? (1024 GMT)

Food for thought: could it be that the trillions central banks poured at struggling
economies are actually prolonging the time it will take for companies to bounce back from the
COVID-19 depths?

So seems to believe Swiss asset manager Pictet.

“Unless these interventions return economies to robust health, they won’t have eradicated
the corporate sector’s underlying vulnerabilities. They are merely distorting the market and
prolonging the time it will take companies to return to health," Pictet writes in a note.

In this scenario, the asset manager expects distressed investments to be booming.

"The vast gap between corporate fundamentals and the price at which companies’ bonds and
stocks trade" is opening big "opportunities for distressed debt and special situations investors
since at least the global financial crisis," Pictet says.

"It is when the economic clouds darken that distressed securities prove their worth."

(Joice Alves)

*****

TECH, HEALTHCARE, PLEASE WELCOME CHEMICALS AND UTILITIES (1010 GMT)

Very few sectors had managed to recover from the March financial crash and make their way to
positive territory so far in 2020.

Healthcare and Tech have been one of the only safe havens in European equities for investors
to weather through the Covid-19 storm during the first half of 2020.

H2 seems a bit different on that front now with utilities and chemicals turning positive
year-on-year in July as you can see below.

That chemicals is pulling off a 2% rise is certainly a good omen for the bulls.

That being said, the STOXX 600 is still 10% down and as you can see on the table below the
chart, not a lot of sectors are even close to the floatation mark.

(Julien Ponthus)

*****

OPENING SNAPSHOT: RISK-OFF ON "MISSION IMPOSSIBLE" (0739 GMT)

European stock markets are clearly not feeling that optimistic on the chances of EU leaders
striking a deal today on what European Council President Charles Michel called "mission
impossible".

With healthcare being the only sector up and tech just barely hanging in there, it's clearly
risk off with the STOXX 600 down 0.7% and all European bourses in the red.

It's interesting to note that the euro is still up, which seems to indicate that there's
still some optimism on trading floors, just not for stocks.

The euro upbeat tone isn't helping euro zone banks. They're usually a bit of a proxy on EU
resilience and they are down 1.3%.

Of course, Natixis, which is losing close to 5% after its parent BPCE denied a buyback,
isn't helping. Julius Baer falling over 5% on its results also calls for some caution but then
gain, UBI Banca jumping 11% after Intesa raised its offer could have compensated somewhat.

Overall, the mood for banks in Europe just isn't positive.

But it's not only banks, other cyclical sector are deep in the red like Traval and Leisure,
down 2%.

Cruise operator Carnival, TUI, ICAG and Lufthansa are down all 5-3%.

There's some good news on the Q2 season front though with Philips, up more than 3%, seeing a
strong rebound in consumer demand in Europe during the second quarter as lockdowns were relaxed.

(Julien Ponthus)

*****

ON THE RADAR: JULIUS BAER, PHILIPS, M&S, HOMEBUILDERS (0651 GMT)

With EU leaders still negotiating terms of the recovery fund after three days of haggling
over a plan to revive economies, futures are pointing to a broadly flat open for European
bourses.

On the corporate front, active client trading during the pandemic helped Julius Baer
post a 43% rise in half-year net profit to 491 million Swiss francs ($523.01 million)
on Monday, a record result for the Swiss wealth manager.

Dutch health technology company Philips expects to return to growth in the second
half of the year, if hospitals and consumers were able to gradually overcome the first shock of
the pandemic.

Vaccine plans: Britain signs deals to secure 90 million doses of two possible COVID-19
vaccines from the Pfizer and BioNTech alliance and French group Valneva
. Meantime, UK company GSK plans to invest 130 million pounds ($163 million) in
German biotech firm CureVac for a 10% stake to work together on a novel type of vaccine.

And more reports on job cuts: British retailer Marks and Spencer Group Plc plans to
announce hundreds of job cuts in the coming week, Sky News reported on Sunday, citing sources.
Ted baker to cut 25% of its UK work force.

Eyes on homebuilders after British property website Rightmove said a mini housing market
boom was gathering pace after a tax cut by finance minister Rishi Sunak.

Shares of auction website Allegro seen up 20% by one trader, on owners' Warsaw listing plans
in September.

Airbus Signs contract with UK Ministry Of Defence for Skynet 6A Satellite.

(Joice Alves)

*****

MORNING CALL: EU STIMULUS CLIFF-HANGER (0530 GMT)

Who would have thought? EU summits often drag on for days but this is close to
unprecedented!

Among all the scenarios for which investors had prepared themselves for, one where EU
leaders would still be negotiating the stimulus package as markets opened on Monday morning was
clearly an unlikely one!

Anyhow, there it is: progress is being made after three days of haggling but Dutch Prime
Minister Mark Rutte has warned the discussions could still fall apart.

Forex traders seem more optimistic than stock investors at this stage: the euro is trading
at a handsome $1.4390, close to a four-month high while stock futures are broadly flat.

This cliff-hanger is going to be a long one with the meeting was adjourned until 1400 GMT.

(Julien Ponthus)

*****

More News
22 Nov 2023 09:48

LONDON BROKER RATINGS: RBC cuts HSBC; Liberum cuts Glencore

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
21 Nov 2023 11:52

GSK to begin phase 3 trials of low-carbon Ventolin inhaler in 2024

(Alliance News) - GSK PLC on Tuesday said it will begin phase 3 trials of a low carbon version of its metered dose inhaler Ventolin using a "next generation" propellant in 2024.

Read more
14 Nov 2023 17:04

LONDON MARKET CLOSE: FTSE 100 underwhelms as stocks jump after US CPI

(Alliance News) - European equities jumped in the wake of a cooler-than-expected US inflation reading, which took some sting out of a recent hawkish reassessment of the Federal Reserve interest rate outlook.

Read more
13 Nov 2023 09:47

GSK hails momelotinib opinion from European Medicines Agency committee

(Alliance News) - GSK PLC on Monday announced that a European Medicines Agency panel has given a positive opinion recommending momelotinib to treat myelofibrosis patients with anaemia.

Read more
9 Nov 2023 15:50

UK dividends calendar - next 7 days

Friday 10 November 
Bodycote PLCdividend payment date
Breedon Group PLCdividend payment date
Chesnara PLCdividend payment date
Finsbury Growth & Income Trust PLCdividend payment date
Invesco Bond Income Plus Ltddividend payment date
JPMorgan Emerging Markets Investment Trust PLCdividend payment date
Kerry Group PLCdividend payment date
Merchants Trust PLCdividend payment date
Mid Wynd International Investment Trust PLCdividend payment date
Mid Wynd International Investment Trust PLCspecial dividend payment date
Montanaro UK Smaller Cos Investment Trust PLCdividend payment date
Senior PLCdividend payment date
Spectris PLCdividend payment date
Spirax-Sarco Engineering PLCdividend payment date
Travis Perkins PLCdividend payment date
Monday 13 November 
no events scheduled 
Tuesday 14 November 
no events scheduled 
Wednesday 15 November 
Coats Group PLCdividend payment date
Ferguson PLCdividend payment date
JP Morgan Mid Cap Investment Trust PLCdividend payment date
Strategic Equity Capital PLCdividend payment date
Thursday 16 November 
abrdn Property Income Trust Ltdex-dividend payment date
Asian Energy Impact Trust PLCex-dividend payment date
Baillie Gifford Japan Trust PLCex-dividend payment date
BlackRock Greater Europe Investment Trust PLCex-dividend payment date
Bunzl PLCex-dividend payment date
Bytes Technology Group PLCex-dividend payment date
Centrica PLCdividend payment date
Coca-Cola Europacific Partners PLCex-dividend payment date
DX Group PLCex-dividend payment date
Empiric Student Property PLCex-dividend payment date
Fonix Mobile PLCex-dividend payment date
GCP Asset Backed Income Fund Ltdex-dividend payment date
GSK PLCex-dividend payment date
Hargreaves Lansdown PLCex-dividend payment date
Henderson Opportunities Trust PLCex-dividend payment date
ICG Enterprise Trust PLCex-dividend payment date
James Halstead PLCex-dividend payment date
Lancashire Holdings Ltdspecial ex-dividend payment date
Majedie Investments PLCex-dividend payment date
Marks & Spencer Group PLCex-dividend payment date
Murray Income Trust PLCex-dividend payment date
New Star Investment Trust PLCex-dividend payment date
NextEnergy Solar Fund Ltdex-dividend payment date
Octopus Renewables Infrastructure Trust PLCex-dividend payment date
Pershing Square Holdings Ltdex-dividend payment date
Personal Group Holdings PLCdividend payment date
Redrow PLCdividend payment date
Regional REIT Ltdex-dividend payment date
Schroder Oriental Income Fund Ltdex-dividend payment date
Scottish American Investment Co PLCex-dividend payment date
SCS Group PLCex-dividend payment date
Shell PLCex-dividend payment date
Supermarket Income REIT PLCdividend payment date
UK Commercial Property REIT Ltdex-dividend payment date
Unilever PLCex-dividend payment date
Wincanton PLCex-dividend payment date
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
8 Nov 2023 09:30

LONDON BROKER RATINGS: UBS downbeat on AJ Bell and Hargreaves Lansdown

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
2 Nov 2023 10:14

LONDON BROKER RATINGS: Bank of America starts Unite Group with 'buy'

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
1 Nov 2023 16:52

LONDON MARKET CLOSE: Stocks prosper ahead of central bank rate calls

(Alliance News) - Stocks in London took their lead from a positive start on Wall Street to close higher as investors prepare for interest rate decisions in the UK and US.

Read more
1 Nov 2023 16:35

London close: Stocks rise ahead of US Fed policy decision

(Sharecast News) - London's stock market finished in positive territory on Wednesday, with investors keeping a keen eye on the upcoming policy announcement from the US Federal Reserve.

Read more
1 Nov 2023 08:51

TOP NEWS: GSK ups guidance as boosted by Shingrix and Arexvy

(Alliance News) - GSK PLC on Wednesday hailed the performance of the world's first approved respiratory syncytial virus vaccine Arexvy, as it reported a rise in profit and revenue.

Read more
1 Nov 2023 08:50

LONDON MARKET OPEN: FTSE 100 up, FTSE 250 down as Aston Martin tumbles

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of key central bank decisions, as investors were cheered by some strong updates from large-cap listings.

Read more
1 Nov 2023 07:40

LONDON BRIEFING: GSK raises annual guidance following Arexvy launch

(Alliance News) - Stocks in London are called higher on Wednesday, with the main focal point for the day being the upcoming US interest rate decision.

Read more
1 Nov 2023 07:27

GSK hikes guidance after strong third quarter

(Sharecast News) - GSK announced a robust third quarter on Wednesday, prompting an upgrade to its full-year guidance.

Read more
30 Oct 2023 09:01

IN BRIEF: GSK says Jemperli meets endpoint in endometrial cancer trial

GSK PLC - Brentford, west London-based pharmaceutical maker - Jemperli, whose generic name is dostarlimab, meets endpoint of overall survival in phase III Ruby trial on adult patients with primary advanced or recurrent endometrial cancer. Jemperli, combined with standard-of-care chemotherapy, followed by dostarlimab, demonstrated a "statistically significant and clinically meaningful benefit" to the patients in the trial.

Read more
30 Oct 2023 07:06

GSK's Jemperli sees success in endometrial cancer trial

(Sharecast News) - GSK reported encouraging outcomes from part one of the 'RUBY' phase three trial evaluating the efficacy of 'Jemperli', or dostarlimab, with standard chemotherapy for treating adult patients with advanced or recurrent endometrial cancer on Monday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.